Document Detail


Cell cycle-dependent modulation of telomerase activity in tumor cells.
MedLine Citation:
PMID:  8650224     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Telomerase is a ribonucleoprotein complex that is thought to add telomeric repeats onto the ends of chromosomes during the replicative phase of the cell cycle. We tested this hypothesis by arresting human tumor cell lines at different stages of the cell cycle. Induction of quiescence by serum deprivation did not affect telomerase activity. Cells arrested at the G1/S phase of the cell cycle showed similar levels of telomerase to asynchronous cultures; progression through the S phase was associated with increased telomerase activity. The highest level of telomerase activity was detected in S-phase cells. In contrast, cells arrested at G2/M phase of the cell cycle were almost devoid of telomerase activity. Diverse cell cycle blockers, including transforming growth factor beta1 and cytotoxic agents, also caused inhibition of telomerase activity. These results establish a direct link between telomerase activity and progression through the cell cycle.
Authors:
X Zhu; R Kumar; M Mandal; N Sharma; H W Sharma; U Dhingra; J A Sokoloski; R Hsiao; R Narayanan
Related Documents :
15863724 - Repair of cyclobutane pyrimidine dimers or dimethylsulfate damage in dna is identical i...
8821324 - Lipofuscin accumulation and ageing of fibroblasts.
19742304 - The g-quadruplex ligand telomestatin impairs binding of topoisomerase iiialpha to g-qua...
9772284 - Expression profile of senescence-associated beta-galactosidase and activation of telome...
22431704 - Characterization and quantification of proliferating cell patterns in endocapillary pro...
18084254 - The intercellular adhesion molecule, cadherin-10, is a marker for human prostate lumina...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Proceedings of the National Academy of Sciences of the United States of America     Volume:  93     ISSN:  0027-8424     ISO Abbreviation:  Proc. Natl. Acad. Sci. U.S.A.     Publication Date:  1996 Jun 
Date Detail:
Created Date:  1996-07-25     Completed Date:  1996-07-25     Revised Date:  2009-11-18    
Medline Journal Info:
Nlm Unique ID:  7505876     Medline TA:  Proc Natl Acad Sci U S A     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  6091-5     Citation Subset:  IM    
Affiliation:
Division of Oncology, Roche Research Center, Hoffman-La Roche, Inc., Nutley, NJ 07110, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Antineoplastic Agents / pharmacology
Cell Cycle*
Humans
Telomerase / antagonists & inhibitors,  metabolism*
Transforming Growth Factor beta / pharmacology
Tumor Cells, Cultured
Grant Support
ID/Acronym/Agency:
CA 56564/CA/NCI NIH HHS
Chemical
Reg. No./Substance:
0/Antineoplastic Agents; 0/Transforming Growth Factor beta; EC 2.7.7.49/Telomerase
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Different cleavage sites are aligned differently in the active site of M1 RNA, the catalytic subunit...
Next Document:  Expression of corticotropin-releasing factor in inflamed tissue is required for intrinsic peripheral...